Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, et al. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non -small -cell lung cancer (START): a randomised, double -blind, phase 3 trial. Lancet Oncol.